Table 1.

Characteristics of the enrolled patients.

	Liraglutide-Treated	Untreated
N of Patients	19	20
Age (years)	50.8 ± 16.6	56.1 ± 13.9
Males (%)	63.2	55.0
Underlying disease (%)
Inflammatory bowel disease	21.1	25.0
Surgical complications	57.9	55.0
Mesenteric ischemia	15.8	15.0
Pseudo-obstruction	5.3	5.0
SBS (n, %)
Type 1	13, 68.4	11, 55.0
Type 2	4, 21.1	5, 25.0
Type 3	2, 10.5	4, 20.0
Small bowel length (n, %)
<100 cm	9, 47.4	8, 40.0
≥100 cm	10, 52.6	12, 60.0
Colon length (%)
<50%	33.3	33.3
≥50%	66.7	66.7